Login / Signup

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.

Prerna AroraAmy KempfInga NehlmeierLuise GraichenSebastian R SchulzAnne CossmannAlexandra Dopfer-JablonkaMartin S WinklerHans-Martin JäckGeorg Martin Norbert BehrensStefan H PöhlmannMarkus Hoffmann
Published in: Cellular & molecular immunology (2022)
Keyphrases
  • sars cov
  • angiotensin converting enzyme
  • respiratory syndrome coronavirus
  • angiotensin ii
  • dna binding
  • binding protein
  • transcription factor
  • coronavirus disease